Cargando…

Proximity-activated nanoparticles: in vitro performance of specific structural modification by enzymatic cleavage

The development and in vitro performance of a modular nanoscale system capable of specific structural modification by enzymatic activity is described in this work. Due to its small physical size and adaptable characteristics, this system has the potential for utilization in targeted delivery systems...

Descripción completa

Detalles Bibliográficos
Autores principales: Adam Smith, R, Sewell, Sarah L, Giorgio, Todd D
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526364/
https://www.ncbi.nlm.nih.gov/pubmed/18488420
_version_ 1782158739896270848
author Adam Smith, R
Sewell, Sarah L
Giorgio, Todd D
author_facet Adam Smith, R
Sewell, Sarah L
Giorgio, Todd D
author_sort Adam Smith, R
collection PubMed
description The development and in vitro performance of a modular nanoscale system capable of specific structural modification by enzymatic activity is described in this work. Due to its small physical size and adaptable characteristics, this system has the potential for utilization in targeted delivery systems and biosensing. Nanoparticle probes were synthesized containing two distinct fluorescent species including a quantum dot base particle and fluorescently labeled cleavable peptide substrate. Activity of these probes was monitored by gel electrophoresis with quantitative cleavage measurements made by fluorometric analysis. The model proximity-activated nanoparticles studied here exhibit significant susceptibility to cleavage by matrix metalloprotease-7 (MMP-7) at physiologically relevant concentrations, with nearly complete cleavage of available substrate molecules after 24 hours. This response is specific to MMP-7 enzyme activity, as cleavage is completely inhibited with the addition of EDTA. Utilization of enzyme-specific modification is a sensitive approach with broad applications for targeted therapeutics and biosensing. The versatility of this nanoparticle system is highlighted in its modular design, as it has the capability to integrate characteristics for detection, biosensing, targeting, and payload delivery into a single, multifunctional nanoparticle structure.
format Text
id pubmed-2526364
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-25263642008-09-04 Proximity-activated nanoparticles: in vitro performance of specific structural modification by enzymatic cleavage Adam Smith, R Sewell, Sarah L Giorgio, Todd D Int J Nanomedicine Original Research The development and in vitro performance of a modular nanoscale system capable of specific structural modification by enzymatic activity is described in this work. Due to its small physical size and adaptable characteristics, this system has the potential for utilization in targeted delivery systems and biosensing. Nanoparticle probes were synthesized containing two distinct fluorescent species including a quantum dot base particle and fluorescently labeled cleavable peptide substrate. Activity of these probes was monitored by gel electrophoresis with quantitative cleavage measurements made by fluorometric analysis. The model proximity-activated nanoparticles studied here exhibit significant susceptibility to cleavage by matrix metalloprotease-7 (MMP-7) at physiologically relevant concentrations, with nearly complete cleavage of available substrate molecules after 24 hours. This response is specific to MMP-7 enzyme activity, as cleavage is completely inhibited with the addition of EDTA. Utilization of enzyme-specific modification is a sensitive approach with broad applications for targeted therapeutics and biosensing. The versatility of this nanoparticle system is highlighted in its modular design, as it has the capability to integrate characteristics for detection, biosensing, targeting, and payload delivery into a single, multifunctional nanoparticle structure. Dove Medical Press 2008-03 2008-03 /pmc/articles/PMC2526364/ /pubmed/18488420 Text en © 2008 Smith et al, publisher and licensee Dove Medical Press Ltd.
spellingShingle Original Research
Adam Smith, R
Sewell, Sarah L
Giorgio, Todd D
Proximity-activated nanoparticles: in vitro performance of specific structural modification by enzymatic cleavage
title Proximity-activated nanoparticles: in vitro performance of specific structural modification by enzymatic cleavage
title_full Proximity-activated nanoparticles: in vitro performance of specific structural modification by enzymatic cleavage
title_fullStr Proximity-activated nanoparticles: in vitro performance of specific structural modification by enzymatic cleavage
title_full_unstemmed Proximity-activated nanoparticles: in vitro performance of specific structural modification by enzymatic cleavage
title_short Proximity-activated nanoparticles: in vitro performance of specific structural modification by enzymatic cleavage
title_sort proximity-activated nanoparticles: in vitro performance of specific structural modification by enzymatic cleavage
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526364/
https://www.ncbi.nlm.nih.gov/pubmed/18488420
work_keys_str_mv AT adamsmithr proximityactivatednanoparticlesinvitroperformanceofspecificstructuralmodificationbyenzymaticcleavage
AT sewellsarahl proximityactivatednanoparticlesinvitroperformanceofspecificstructuralmodificationbyenzymaticcleavage
AT giorgiotoddd proximityactivatednanoparticlesinvitroperformanceofspecificstructuralmodificationbyenzymaticcleavage